Angela Johana Espejo-Mojica

9PUBLICATIONS
23CO-AUTHORS
NeurogeneticsGlycoconjugatesCheminformatics and quantitative structure-activity relationshipsMedical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
Modeling Tay-Sachs Disease in Astrocyte-like Cells Reveals Significant Changes in the Transcriptomic Profile.

|Feb 27, 2026
Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB.

Nissrine Ballout, Jérôme Désiré, Angela Johana Espejo-Mojica

|Sep 28, 2024
Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction.

Sara M Villada-Troncoso, Jenny Andrea Arévalo-Romero, Vanessa Hernández Rivera

|Jun 03, 2024
Identification of Orthosteric and Allosteric Pharmacological Chaperones for Mucopolysaccharidosis Type IIIB.

Juan Camilo Losada, Heidy Triana, Egdda Vanegas

|Sep 23, 2022
CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors.

Andrés Felipe Leal, Javier Cifuentes, Valentina Quezada

|Sep 03, 2022
Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based nanoparticles.

Andrés Felipe Leal, Javier Cifuentes, Carlos Emilio Torres

Pageof 2

Frequent Collaborators

8 joint publications

Carlos Javier Alméciga-Díaz

4 joint publications

Andrés Felipe Leal

3 joint publications

Luis Humberto Reyes

3 joint publications

Juan Carlos Cruz